NCT00418028View on ClinicalTrials.gov

Standard Versus Continuous Capecitabine in Advanced Breast Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2011

Study Completion Date

January 31, 2015

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Capecitabine

Trial Locations (1)

28040

Hospital Clinico San Carlos, Madrid

All Listed Sponsors
collaborator

Complexo Hospitalario Universitario de A Coruña

OTHER

lead

Hospital San Carlos, Madrid

OTHER

NCT00418028 - Standard Versus Continuous Capecitabine in Advanced Breast Cancer | Biotech Hunter | Biotech Hunter